• No se han encontrado resultados

El factor de necrosis tumoral alfa (FNT α) en la patogenesis de la artritis reumatoide y el riesgo de tuberculosis con infliximab (un agente ANTI FNT α)

N/A
N/A
Protected

Academic year: 2020

Share "El factor de necrosis tumoral alfa (FNT α) en la patogenesis de la artritis reumatoide y el riesgo de tuberculosis con infliximab (un agente ANTI FNT α)"

Copied!
7
0
0

Texto completo

Loading

Referencias

Documento similar

Methods: Taking into account a series of inflammatory and oxidative stress biomarkers (C-reactive protein (CRP), tumor necrosis factor (TNF), 4-hydroxynonenal (HNE) and

Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in

The analysis of low-frequency genetic variants mapping to the TNF signaling pathway using the SKAT-O test showed that the damaging burden is different between anti-TNF

Recent evidence suggests a role for TNF superfamily member Tumor necrosis factor-like weak inducer of apoptosis (TWEAK, Apo3L, or TNFSF12) in both AKI and CKD, where it has been

Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: results of a phase I

Conversely, the evaluation of mRNA levels of genes encoding pro-in flammatory cytokines [interleukin-1 beta (IL-1 b ), tumor necrosis factor alpha (TNF a ), and transforming

Therefore, we aimed to evaluate the potential of the concordant presence of RF, anti-CCP and anti-carbamylated protein antibodies to improve current RA classification among

Fortunately, physicians appear to be aware of the need to monitor CVD risk in patients with active RA: a study of 14,503 patients in world-wide data from the SUrvey of